Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Postgrad Med. 2019 Jul 23;131(6):376–382. doi: 10.1080/00325481.2019.1643635

Table 2:

Proportions (with 95% CI) of individuals in each insulin use category with high vs. low insulin resistance across three outcomes

Alive Dead MACE No MACE Has DKD No DKD
High HOMA p=0.04 p < 0.01 p < 0.01
Insulin 16.95% (13.68 – 20.82) 3.86% (2.32 – 6.36) 8.46% (6.33 – 11.22) 12.34% (9.20 – 16.37) 11.28% (8.35 – 15.08) 9.51% (7.28 – 12.33)
No Insulin 70.28% (65.92 – 74.29) 8.91% (7.06 – 11.20) 15.99% (12.89 – 19.68) 63.21% (57.86 – 68.26) 28.21% (24.33 – 32.45) 51.00% (46.48 – 55.49)
Low HOMA p=0.22 p = 0.30 p = 0.25
Insulin 17.49% (13.31 – 22.64) 4.20% (2.46 – 7.10) 7.77% (5.07 – 11.73) 13.35% (9.10 – 19.16) 10.01% (7.32 – 13.58) 12.11% (7.99 – 17.94)
No Insulin 67.89% (63.02 – 72.41) 10.41% (7.61 – 14.09) 21.88% (17.39 – 27.15) 57.00% (50.58 – 63.19) 28.12% (24.04 – 32.59) 49.75% (43.85 – 55.66)

Bold text indicates significance at p<0.05 level